Mr. Edge is the president of Synchrogenix, Certara’s regulatory science division. Synchrogenix provides a wide range of services and technologies to support sponsors throughout the regulatory process, including developing and submitting all the requisite documents for new drug, medical device and biologics applications. Prior to joining Certara, Justin worked at GfK, a leading global research and analytics firm with 13,000 employees, where he most recently led the company’s healthcare business unit, managing teams in more than 20 countries. A 25 year industry veteran, Justin is a frequent conference speaker, chair and contributor for Eye for Pharma, ARF, EphMRA, PBIRG, PMRG, CRC, and others.
Justin Edge President, Regulatory and Access